Home Daily Stock Opinions and Ratings Moderna (MRNA-Q)

Trending stocks today

High Liner Foods Logistec Corp Northrop Grumman TC Energy Visa Inc. Martinrea Minto Apartment REIT Equinix, Inc. Cisco Check Point Software Tech Block Inc Bed Bath & Beyond First Capital Realty First Industrial Realty Trust Dream Industrial REIT BETAPRO SP500 DAILY INVERSE ETF iShares 20+ Year Treasury Bond ETF BMO Covered Call Utilities ETF

Moderna (MRNA-Q)

111 watching

NASDAQ:MRNA

147.44
1.36 (0.91%) 1d
Mar 30, 2023, 8:00 pm
0
PARTIAL BUY

Moderna(MRNA-Q)

17/03/2023
Moderna

Likes it long term. They will reveal data on a personalized cancer vaccine coming up. But short term it's volatile, anybody's guess.

Pharma & Healthcare
Stephen Weiss, Founder, Short Hills Capital Partners
N/A
Owned
UnlockRating
premium

It’s a Buzzing Stocks opinion which is available only for Premium members

It's the review of the most popular stocks on social media. It's posted weekly to give you another view on the trending stocks, so you will not waste your precious time on scrolling social media feeds.

TOP PICK

Moderna(MRNA-Q)

23/02/2023
Moderna

Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA. Social media mentions are up 160% in the past 24h.

Pharma & Healthcare
The Weekly Buzzing Stocks by Billy Kawasaki
$145.790
Unknown
RISKY

Moderna(MRNA-Q)

14/12/2022
Moderna
They just had a breakthrough with a cancer drug they had long been developing. With that, Moderna doesn't need the potential Covid-vaccine business with China (if that happens there). After a 40-point rally, it is a little speculative.
Pharma & Healthcare
Jim Cramer - Mad Money
$213.955
Unknown
UnlockRating
BUY

Moderna(MRNA-Q)

28/10/2022
Moderna
They report next week. Not sure how it'll pay out because of the slower uptake of their 4th booster shot, but they have an incredible pipeline.
Pharma & Healthcare
Stephen Weiss, Founder, Short Hills Capital Partners
$146.550
Owned
UnlockRating
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Moderna(MRNA-Q)

29/09/2022
Moderna
(A Top Pick Jul 07/22, Down 30.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MRNA has triggered its stop at $120. To remain disciplined, we recommend covering the position at this time.
Pharma & Healthcare
The Panic-Proof Portfolio (Stockchase Research)
$118.190
Unknown
UnlockRating
COMMENT

Moderna(MRNA-Q)

21/09/2022
Moderna
It has suffered enough. A well-run company, but shares can fall lower. Enough is enough.
Pharma & Healthcare
Jim Cramer - Mad Money
$125.760
Unknown
UnlockRating
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Moderna(MRNA-Q)

07/07/2022
Moderna
Stockchase Research Editor: Michael O'Reilly Trading at only 5x earnings, this is one of the least expensive stocks in the S&P500. The company is looking to expand its COVID vaccine in Europe and the US for children under 6 years. Recently reported earnings smashed analyst expectations by over 65% and is generating a ROE over 120%. The company has been prudently using a small portion of cash reserves to help aggressively buy back shares and retire debt. We recommend a stop loss at $120, looking to achieve $228 -- upside potential over 42%. Yield 0% (Analysts’ price target is $228.00)
Pharma & Healthcare
The Panic-Proof Portfolio (Stockchase Research)
$172.340
Unknown
UnlockRating
BUY

Moderna(MRNA-Q)

13/05/2022
Moderna
Biotechs have strong balance sheets, better than a few years ago. Likes this as well as Amgen. Better to buy individual biotech stocks over ETFs.
Pharma & Healthcare
Pete Najarian
$137.850
Unknown
UnlockRating
BUY

Moderna(MRNA-Q)

13/05/2022
Moderna
Has lightened his holding (and all his stocks) because of this market, but it remains one of the cheapest stocks out there with a lot of cash in order to buy another company. Their drug pipeline continues to grow. It's the best biotech out there.
Pharma & Healthcare
Stephen Weiss, Founder, Short Hills Capital Partners
$137.910
Owned
UnlockRating
DON'T BUY

Moderna(MRNA-Q)

12/05/2022
Moderna
Chart has come full circle. Covid vaccine was a tremendous short-term win for the company and society. Revenues are trailing off for the next 2 years. Avoid the rockets and torpedoes. Look at PFE instead.
Pharma & Healthcare
Paul MacDonald
$129.255
No
UnlockRating
COMMENT

Moderna(MRNA-Q)

29/04/2022
Moderna
They report Wednesday. They made a lot of cash during the pandemic, but they need to expand and can't be a one-trick pony. Need to broaden their portfolio.
Pharma & Healthcare
Jim Cramer - Mad Money
$134.410
Unknown
UnlockRating
BUY on WEAKNESS

Moderna(MRNA-Q)

14/02/2022
Moderna
Shares are plunging today. They sold over $18 billion of vaccines for 2022. All vaccine stocks have fallen for the same reason: Covid is ending. He's short calls and long puts for Moderna (has been so for many months). Post-vaccine world, he thinks this will be the most-valuable healthcare company, because they have a platform that's grown from 21 therapeutics and vaccines to over 40 in the span of a year. The future is extremely bright. But biotech stocks are event-driven. So, no events, then shorting happens and sellers get impatient.
Pharma & Healthcare
Stephen Weiss, Founder, Short Hills Capital Partners
$140.010
Owned
UnlockRating
WATCH

Moderna(MRNA-Q)

24/01/2022
Moderna
It made a ton of money since Covid, but it hasn't done much with that cash and didn't develop a pill treatment like Pfizer. He wishes they would buy weaker biotechs with that cash to grow. He expects/hope that.
Pharma & Healthcare
Jim Cramer - Mad Money
$157.270
No
UnlockRating
DON'T BUY

Moderna(MRNA-Q)

04/01/2022
Moderna
Fallen a lot recently. If we believe that Covid becomes endemic and we don't all need shots, what's going to happen to MRNA? Crazy cheap at 8-9x next year's earnings, beautiful balance sheet, technology works, but what's the next catalyst? He tends to stay away from biotechs and pharmas, as the science is too hard to understand.
Pharma & Healthcare
Barry Schwartz
$228.980
No
UnlockRating
COMMENT

Moderna(MRNA-Q)

03/01/2022
Moderna
Among the 10 top performers on the S&P of 2021 #3, up 143%. He doubts MRNA can repeat this increase unless everybody gets a fourth dose of their vaccine or can diversify into, say, cancer vaccines. He loves management, but the stock isn't pricing in the chance the Omicron will come and go quickly (and result in a bad kind of herd immunity).
Pharma & Healthcare
Jim Cramer - Mad Money
$235.050
No
UnlockRating
Showing 1 to 15 of 37 entries
Next PageNext Page

Moderna(MRNA-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 6

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 7

Stockchase rating for Moderna is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Moderna(MRNA-Q) Frequently Asked Questions

What is Moderna stock symbol?

Moderna is a American stock, trading under the symbol MRNA-Q on the NASDAQ (MRNA). It is usually referred to as NASDAQ:MRNA or MRNA-Q

Is Moderna a buy or a sell?

In the last year, 7 stock analysts published opinions about MRNA-Q. 6 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Moderna.

Is Moderna a good investment or a top pick?

Moderna was recommended as a Top Pick by on . Read the latest stock experts ratings for Moderna.

Why is Moderna stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Moderna worth watching?

7 stock analysts on Stockchase covered Moderna In the last year. It is a trending stock that is worth watching.

What is Moderna stock price?

On 2023-03-30, Moderna (MRNA-Q) stock closed at a price of $147.44.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

REI.UN-TRioCan Real Estate Investment
RioCan Real Estate Investment
$20.08
0.02 (0.10%)
IIP.UN-TInterRent REIT
InterRent REIT
$13.38
0.26 (1.91%)
SMU.UN-TSUMMIT INDUSTRIAL INCOME REIT RCPTS
SUMMIT INDUSTRIAL INCOME REIT RCPTS
$23.48
0.02 (0.09%)
SUI-NSun Communities
Sun Communities
$139.37
2.31 (1.63%)
BEI.UN-TBoardwalk REIT
Boardwalk REIT
$54.60
0.48 (0.87%)
Advertising

Today's Top Picks

ZWU-TBMO Covered Call Utilities ETF
BMO Covered Call Utilities ETF
$11.36
0.08 (0.70%)
TLT-QiShares 20+ Year Treasury Bond ETF
iShares 20+ Year Treasury Bond ETF
$104.80
0.48 (0.46%)
HIU-TBETAPRO SP500 DAILY INVERSE ETF
BETAPRO SP500 DAILY INVERSE ETF
$14.62
-0.09 (-0.62%)
DIR.UN-TDream Industrial REIT
Dream Industrial REIT
$14.38
0.17 (1.16%)
FR-NFirst Industrial Realty Trust
First Industrial Realty Trust
$52.06
0.16 (0.31%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

NWH.UN-TNorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust
$8.52
-0.02 (-0.27%)
CSH.UN-TChartwell Seniors Housing
Chartwell Seniors Housing
$8.55
0.10 (1.17%)
D.UN-TDream Office REIT
Dream Office REIT
$14.26
0.22 (1.54%)
VRT-NVertiv Holdings
Vertiv Holdings
$13.80
0.09 (0.65%)
SPH-NSuburban Propane Partners LP
Suburban Propane Partners LP
$15.22
-0.01 (-0.07%)

Most Recent Experts

Moffs

Andrew Moffs

Vision Capital

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Bolton

Kim Bolton

Black Swan Dexteritas

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.